Natriuretic peptides as markers of preclinical cardiac diseases in obesity

European Journal of Clinical Investigation

Volumn 34, Issue 5, 2004, Pages 342-348

  Grandi, A M ^a,c   Laurita, E ^a   Selva, E ^a   Piantanida, E ^a   Imperiale, D ^a   Giovanella, L ^b   Guasti, L ^a   Venco, A ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c University of Insubria ^*  (Italy)

Author keywords

Diastolic function; Hypertension; Natriuretic peptides; Obesity

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLE; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; LEAN BODY WEIGHT; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLE;

ADULT; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; FEMALE; HEART DISEASES; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; OBESITY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 2942607370     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01348.x     Document Type: Article

References (31)

1. Wilsgaard T, Schirmer H, Arnesen E. Impact of body weight on blood pressure with a focus on sex differences: the Tromso study 1986-95. Arch Intern Med 2000;160:2847-53.
2. Kolanowski J. Obesity and hypertension: from pathophysiology to treatment. Int J Obes 1999;23 (Suppl. 1):42-6.
3. Stevo J, Valentin MC, Palatini P. Overweight and hypertension. A 2-way street? Hypertension 2000;35:807-13.
4. Zeigler DW, Patel KP. Reduced renal responses to an acute saline load in obese Zucker rats. Am J Physiol 1991;261 (3 Pt 2): R712-8.
5. Yoshimoto T, Naruse M, Naruse K, Fujimaki Y, Tanabe A, Muraki T et al. Modulation of vascular natriuretic peptide receptor gene expression in hypertensive and obese hyperglycemic rats. Endocrinology 1995;136:2427-34.
6. Dessi-Fulgheri P, Sarzani P, Rappelli A. The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects. J Nephrol 1998;11:296-9.
7. Sarzani R, Dessì-Fulgheri P, Salvi F, Serenelli M, Spagnolo D, Cola G et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypenens 1999;17:1301-5.
8. Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P et al. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol 1994;53:120-6.
9. Mureddu GF, De Simone G, Greco R, Rosato GF, Contaldo F. Left ventricular filling in arterial hypertension. Influence of obesity and hemodynamic and structural confounders. Hypertension 1997;29:544-50.
10. Grandi AM, Zanzi P, Piantanida E, Gaudio G, Bertolini A, Guasti L et al. Obesity and left ventricular diastolic function: non invasive study in normotensives and newly diagnosed never-treated hypertensives. Int J Obes 2000;24:954-8.
11. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996;28:22-30.
12. Cheung BMY. Plasma concentration of brain natriuretic peptides is related to diastolic function in hypertension. Clin Exp Pharmacol Physiol 1997;24:966-8.
13. Grandi AM, Zanzi P, Ceriani L, Gaudio G, Bertolini A, Giovanella L et al. Relationship between left ventricular diastolic function and atrial natriuretic factor in never-treated mild hypertensives. Am J Hypertens 1997;10:946-50.
14. Yasumoto K, Masanobu T, Hitoshi U, Tomita S, Tomoda F, Inoue H. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension. Am J Hypertens 1999;12:921-4.
15. Upton MT, Gibson DG. The study of left ventricular function from digitised echocardiograms. Prog Cardiovasc Dis 1978;20:359-84.
16. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-8.
17. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, De Divitiis O et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992;20:1251-60.
18. Yamamoto K, Burnett J, Jougasaki M, Nishimura R, Bailey K, Saito Y et al. Superiority of brain natriuretic peptide as a marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94.
19. Kenchaian S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al. Obesity and risk of heart failure. N Engl J Med 2002;347:305-13.
20. Grandi AM, Bignotti M, Gaudio G, Zanzi P, Guasti L, Venco A. Ambulatory blood pressure and left ventricular changes during antihypertensive treatment: perindopril versus isradipine. J Cardiovasc Pharmacol 1995,26:737-41.
21. Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension. Comparison of six antihypertensive agents. Circulation 1997;95:2007-14.
22. Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995;98:257-65.
23. Krauss RM, Winston M, Fletcher BJ, Grundy SM. Obesity. Impact on cardiovascular disease. Circulation 1998;98:1472-6.
24. McMurray R, Vesely D. Weight reduction decreases the circulating concentration of the N-terminus of the ANF prohormone. Am J Med Sci 1992;303:2-8.
25. Dessí-Fulgheri P, Sarzani R, Serenelli M, Tamburrini P, Spagnolo D, Giantomassi L et al. Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension 1999;33:658-62.
26. Alpert MA, Boyd T, Mulekar M, Cohen M, Massey C, Fan M et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 1997;80:736-40.
27. Lee CH, Hogan JC, Gibson DG. Diastolic disease in left ventricular hypertrophy, comparison of M-Mode and Doppler echocardiography for the assessment of rapid ventricular filling. Br Heart J 1991;65:194-200.
28. Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G et al. Plasma atrial natriuretic peptide and natriuretic receptor gene expression in adipose tissue of normotensive and hypertensive patients. J Hypertens 1997;15:1695-9.
29. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PWF et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002;90:254-8.
30. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PWF et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004;109:594-600.
31. Chakko S, Mayor M, Allison MD, Kessler K, Meterson BJ, Meyerberg RJ. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy in obesity. Am J Cardiol 1991;68:95-8.